A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas

Purpose: Gene expression studies provide molecular insights improving the classification of patients with high-grade gliomas. We have developed a risk estimation strategy based on a combined analysis of gene expression data to search for robust biomarkers associated with outcome in these tumors. Experimental Design: We performed a meta-analysis using 3 publicly available malignant gliomas microarray data sets (267 patients) to define the genes related to both glioma malignancy and patient outcome. These biomarkers were used to construct a risk-score equation based on a Cox proportional hazards model on a subset of 144 patients. External validations were performed on microarray data (59 patients) and on RT-qPCR data (194 patients). The risk-score model performances (discrimination and calibration) were evaluated and compared with that of clinical risk factors, MGMT promoter methylation status, and IDH1 mutational status. Results: This interstudy cross-validation approach allowed the identification of a 4-gene signature highly correlated to survival (CHAF1B, PDLIM4, EDNRB, and HJURP), from which an optimal survival model was built (P < 0.001 in training and validation sets). Multivariate analysis showed that the 4-gene risk score was strongly and independently associated with survival (hazard ratio = 0.46; 95% CI, 0.26–0.81; P = 0.007). Performance estimations indicated that this score added beyond standard clinical parameters and beyond both the MGMT methylation status and the IDH1 mutational status in terms of discrimination (C statistics, 0.827 versus 0.835; P < 0.001). Conclusion: The 4-gene signature provides an independent risk score strongly associated with outcome of patients with high-grade gliomas. Clin Cancer Res; 17(2); 317–27. ©2011 AACR.

[1]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[2]  Michael M Lieber,et al.  PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  T. Golub,et al.  Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. , 2003, Cancer research.

[4]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[5]  A. Brodbelt,et al.  Molecular Diagnostics , 2011, Human Genomics.

[6]  Rainer Breitling,et al.  A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments , 2008, Bioinform..

[7]  S. Ishii,et al.  Using gene expression profiling to identify a prognostic molecular spectrum in gliomas , 2008, Cancer science.

[8]  C. Mignogna,et al.  Chromatin assembly factor‐1 (CAF‐1)‐mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? , 2007, Histopathology.

[9]  Yusuke Nakamura,et al.  HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres , 2009, Cell.

[10]  S. Horvath,et al.  Gene Expression Profiling of Gliomas Strongly Predicts Survival , 2004, Cancer Research.

[11]  Frank M. Sacks,et al.  IDH 1 and IDH 2 Mutations in Gliomas , 2009 .

[12]  Madan Arora,et al.  Primary brain tumors in adults. , 2008, American family physician.

[13]  K. Aldape,et al.  A multigene predictor of outcome in glioblastoma. , 2010, Neuro-oncology.

[14]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[15]  R. Mirimanoff,et al.  MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.

[16]  A. Bresnick,et al.  Integrin α6β4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin* , 2009, Journal of Biological Chemistry.

[17]  J. Klijanienko,et al.  Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells , 2004, Cancer Research.

[18]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[19]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[20]  K. Hoang-Xuan,et al.  Primary brain tumours in adults , 2003, The Lancet.

[21]  J. Mosser,et al.  Integrative genome‐wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression , 2009, Genes, chromosomes & cancer.

[22]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[23]  F. Ducray,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[24]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[25]  R. Schwartz,et al.  Primary brain tumors in adults. , 1992, Seminars in ultrasound, CT, and MR.

[26]  K. Aldape,et al.  Molecular predictors in glioblastoma: toward personalized therapy. , 2008, Archives of neurology.

[27]  J. Nelson,et al.  The endothelin axis: emerging role in cancer , 2003, Nature Reviews Cancer.

[28]  David N Louis,et al.  Molecular pathology of malignant gliomas. , 2006, Annual review of pathology.

[29]  Tom C. Freeman,et al.  Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data , 2008, Molecular Cancer Therapeutics.

[30]  Yuri Kotliarov,et al.  Unsupervised analysis of transcriptomic profiles reveals six glioma subtypes. , 2009, Cancer research.

[31]  Jayant P. Menon,et al.  Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. , 2006, Cancer cell.

[32]  Rainer Breitling,et al.  RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..

[33]  J. Yates,et al.  Centromere-Specific Assembly of CENP-A Nucleosomes Is Mediated by HJURP , 2009, Cell.

[34]  D. Nelson,et al.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. , 1993, Journal of the National Cancer Institute.

[35]  D. Botstein,et al.  Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Yusuke Nakamura,et al.  Activation of Holliday junction recognizing protein involved in the chromosomal stability and immortality of cancer cells. , 2007, Cancer research.

[37]  S. Lê,et al.  BMC Genomics BioMed Central Methodology article Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach , 2008 .

[38]  E. Estey,et al.  RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis. , 2007, Cancer research.